We therefore propose that the regulatory variants rs116525449 and rs79644959 of ARL14 may influence immune-mediated resistance to SM by influencing the distribution of MHC class II antigens on the surface of antigen-presenting cells and hence activation of T lymphocytes. The gene discussed is ARL14; the disease is systemic mastocytosis.